期刊文献+

不同月龄p21^HBsAg/HBsAg和p21^HBX/HBX转基因小鼠血清酶含量的测定 被引量:2

Determination of Seroenzyme Activity of p21^(HBsAg/HbsAg) and p21^(HBX/HBX) Transgenic Mice on the Different Age
下载PDF
导出
摘要 目的测定p21HBsAg/HBsAg和p21HBX/HBX转基因小鼠纯合型及野生型小鼠的血清酶,探讨各种血清酶在两种纯合型小鼠及野生型小鼠的变化规律。方法采用荷兰半自动生化分析仪Ⅱ对于肝功能相关的7种血清酶进行测定,应用SSPS10统计学软件进行T检验及方差分析比较。结果p21HBsAg/HBsAg和p21HBX/HBX转基因小鼠不同年龄、不同的指标雌雄之间差异显著,并且随着年龄的变化,雌雄之间的变化规律不同。结论p21HBsAg/HBsAg和p21HBX/HBX转基因小鼠的血清酶在不同的年龄具有一定的变化规律,说明p21HBsAg/HBsAg和p21HBX/HBX转基因小鼠的血清酶具有一定的特征,为其功能性研究及临床检验具有重要参考价值。 Objective To obtain the basic data of seroenzyme activity of p 21^HBsAg/HbsAg and p 21^HBX/HBX transgenic mice on the different age, and To study the infection of the seroenzyme activity, of the p 21^HBsAg/HbsAg and p 21^HBX/HBX was introduced into p21 locus of the mouse. Methods The seroenzyme activity of seven strain were deteminated in different age of p 21^HBsAg/HbsAg and p 21^HBX/HBX transgenic mice for ViTALAB made in Holland. To compare T-test and Analysis of Variance for SSPS10. Results There were a lot significant differences in mice between sexes(male and female mice) and ages. There are significant differences on the seroenzyme activity of the p 21^HBsAg/HbsAg and p 21^HBX/HBX transgenic mice and Wild-types. Conclusion there are infection on some seroenzyme activity of the p 21^HBsAg/HbsAg and p 21^HBX/HBX was introduced into p21 locus of the mouse. The activities of the seroenzymes have been changed due to the p 21^HBsAg/HbsAg and p 21^HBX/HBX was introduced into p21 locus of the mouse.
出处 《中国比较医学杂志》 CAS 2009年第1期11-14,共4页 Chinese Journal of Comparative Medicine
基金 863课题2002BA711A02-5
关键词 p21HBsAg/HBsAg转基因小鼠 p21HBX/HBX转基因小鼠 血清酶 p21^HBAg/HBsAg transgenic mice p21^HBX/HBX transgenic mice, Seroenzyme activity
  • 相关文献

参考文献4

二级参考文献19

  • 1孙强,薛猛,刘英,冯洁,岳挺,薛整风,刘全海,李厚达.HBsAg转基因小鼠模型的建立及其用于基因治疗研究初探[J].中国比较医学杂志,2004,14(6):321-324. 被引量:4
  • 2Sallberg M, Hughes J, Javadian A, et al. Genetic immunization of chimpanzees chronically infected with the hepatitis B virus, using a recombinant retroviral vector encoding the hepatitis B virus core antigen [J]. Hum Gene Ther, 1998, 9: 1719- 1729.
  • 3Chisari FV. Hepatitis B virus transgenic mice: insights into the virus and the disease[J]. Hepatology, 1995, 22: 1316- 1325.
  • 4Lin OS, Keeffe EB. Current treatment strategies for chronic hepatitis B and C [J]. Annu Rev Med, 2001, 52: 29-49.
  • 5Akbar SK, Onji M. Hepatitis B virus (HBV)-transgenic mice as an investigative tool to study immunopathology during HBV infection [J]. Int J Exp Pathol, 1998, 79: 279-291.
  • 6Couillin I, Pol S, Mancini M, et al. Specific vaccine therapy in chronic hepatitis B: induction of T cell proliferative responses specific for envelope antigens [J]. J Infect Dis, 1999, 180: 15-26.
  • 7Gurunathan S, Klinman DM, Seder RA. DNA vaccines: immunology, application, and optimization [ J ]. Annu Rev Immunol, 2000,18: 927 - 937.
  • 8Arbuthnot P, Kew M. Hepatitis B virus and hepatocellular carcinoma[J] .Int J Exp Pathol,2001,82(2) :77- 1130.
  • 9Chisari FV. Rous-Whipple Award Lecture. Viruses, immunity, and cancer: lessons from hepatitis B [J]. Am J Pathol, 2000, 156(4) :1117 - 1132.
  • 10Wang Y, Cui F, Lv Y, et el. HbsAg and HBx knocked into the p21 locus causes hepatocellular carcinoma in mice, Hepatology, 2003, 39(2) :318 - 324.

共引文献7

同被引文献11

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部